DOCSLIB.ORG

Koch Shrna Gene Webpage

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Koch Shrna Gene Webpage Symbol SEPT9 ADAM30 AEN AMBP ARHGEF12 ATG16L2 BCAS3 A1CF ADAM32 AFF3 AMBRA1 ARHGEF17 ATG2A BCKDK AAK1 ADAM33 AGAP2 AMHR2 ARHGEF2 ATG3 BCL10 AATK ADAM7 AGER AMPH ARHGEF4 ATG4B BCL11A ABCA1 ADAM8 AGK ANAPC2 ARHGEF6 ATG4C BCL11B ABCA3 ADAM9 AGL ANG ARHGEF7 ATG4D BCL2 ABCB1 ADAMDEC1 AGPAT9 ANGPT2 ARID1A ATG5 BCL2L1 ABCB4 ADAMTS1 AGR3 ANGPTL4 ARID1B ATG7 BCL2L11 ABCC1 ADAMTS10 AHR ANKK1 ARID2 ATM BCL2L2 ABCC10 ADAMTS12 AIMP2 ANKRD30A ARID3A ATMIN BCL3 ABCC2 ADAMTS13 AIP ANO1 ARID3B ATP1B3 BCL6 ABCG2 ADAMTS14 AJAP1 ANXA1 ARID4B ATP2B4 BCL7A ABI1 ADAMTS15 AK1 ANXA2 ARID5A ATP7A BCL9 ABL1 ADAMTS16 AK2 ANXA6 ARID5B ATP7B BCR ABL2 ADAMTS17 AK3 ANXA7 ARL11 ATR BECN1 ACIN1 ADAMTS18 AK4 APAF1 ARNT ATRX BFAR ACP1 ADAMTS19 AK5 APC ARSB ATXN1 BIK ACPP ADAMTS2 AK7 APCDD1 ARSG ATXN2 BIN1 ACSL4 ADAMTS20 AK8 APEX1 ASAP1 AURKA BIN2 ACTN1 ADAMTS3 AKAP1 APOBEC1 ASAP3 AURKB BIRC2 ACVR1 ADAMTS4 AKAP13 APOBEC2 ASB15 AURKC BIRC3 ACVR1B ADAMTS5 AKAP3 APOBEC3G ASCC1 AXIN1 BIRC5 ACVR1C ADAMTS7 AKAP8L AQP1 ASCC3 AXIN2 BIRC7 ACVR2A ADAMTS8 AKR1B10 AQP5 ASCL1 AXL BLCAP ACVR2B ADAMTS9 AKR1C1 AQP7 ASCL2 AZGP1 BLK ACVRL1 ADAR AKR1C3 AR ASF1A BACE1 BLM AD026 ADARB1 AKT1 ARAF ASH1L BAD BMI1 ADAM10 ADARB2 AKT2 AREG ASH2L BAG1 BMP2 ADAM11 ADAT2 AKT3 ARF1 ASNS BAG4 BMP2K ADAM12 ADCK1 ALCAM ARF4 ASPH BANF1 BMP2KL ADAM15 ADCK2 ALDH18A1 ARF5 ASPSCR1 BAP1 BMPR1A ADAM17 ADCK3 ALK ARF6 ASS1 BARD1 BMPR1B ADAM18 ADCK4 ALKBH2 ARHGAP12 ASTE1 BAX BMPR2 ADAM19 ADCK5 ALKBH3 ARHGAP22 ASXL1 BAZ1A BMX ADAM2 ADCY6 ALKBH8 ARHGAP25 ATF1 BAZ1B BNIP3 ADAM20 ADK ALOX15 ARHGAP26 ATF2 BAZ2A BPTF ADAM21 ADORA1 ALOX5 ARHGAP5 ATF3 BAZ2B BRAF ADAM22 ADORA2B ALPK1 ARHGAP8 ATF4 BBC3 BRCA1 ADAM23 ADPGK ALPK2 ARHGDIB ATF6 BCAR1 BRCA2 ADAM28 ADRBK1 ALPK3 ARHGEF10 ATG12 BCAR3 BRD1 ADAM29 ADRBK2 AMACR ARHGEF11 ATG16L1 BCAS1 BRD2 Symbol BRD3 C8orf4 CBL CDC25B CDK5RAP2 CHD5 CNKSR1 BRD4 C9orf95 CBLB CDC25C CDK6 CHD8 CNKSR2 BRD7 C9orf96 CBLC CDC26 CDK7 CHD9 CNKSR3 BRD8 CA12 CBX1 CDC37 CDK8 CHEK1 CNN1 BRD9 CA2 CBX2 CDC42 CDK9 CHEK2 CNOT6L BRDT CA9 CBX4 CDC42BPA CDKL1 CHFR CNOT7 BRIP1 CABLES1 CBX5 CDC42BPB CDKL2 CHIC2 CNP BRMS1 CABYR CBX6 CDC42BPG CDKL3 CHKA CNTNAP2 BRPF1 CADM1 CBX7 CDC42EP1 CDKL4 CHKB COASY BRPF3 CALM1 CBX8 CDC5L CDKL5 CHL1 COG1 BRSK1 CALM2 CCBE1 CDC7 CDKN1A CHMP4A COG2 BRSK2 CALM3 CCBP2 CDC73 CDKN1B CHMP4B COG8 BRWD1 CALR CCDC36 CDCA7 CDKN1C CHMP4C COL4A3BP BRWD3 CALR3 CCDC6 CDCA8 CDKN2A CHN1 COMMD1 BSG CAMK1 CCKBR CDCP1 CDKN2B CHRD CPA3 BTBD7 CAMK1D CCL2 CDH1 CDKN2C CHUK CPE BTC CAMK1G CCL20 CDH11 CDKN2D CIB1 CPEB2 BTG1 CAMK2A CCL21 CDH13 CDKN3 CIB4 CPEB3 BTK CAMK2B CCL4 CDH2 CDX1 CIC CPEB4 BTRC CAMK2D CCL5 CDH3 CDX2 CIT CPNE3 BUB1 CAMK2G CCNA2 CDK1 CEBPA CITED1 CPT1C BUB1B CAMK4 CCNB1 CDK10 CELF1 CITED4 CRABP1 BUD31 CAMKK1 CCNB1IP1 CDK11A CELF2 CKAP5 CREB1 C11orf30 CAMKK2 CCNB2 CDK11B CELSR1 CKB CREB3L2 C11orf43 CAMKV CCNB3 CDK12 CEP290 CKM CREB3L4 C12orf33 CAPN1 CCND1 CDK13 CEP55 CKMT1A CREBBP C12orf5 CARD11 CCND2 CDK14 CERK CKMT1B CREBZF C14orf49 CARD16 CCND3 CDK15 CERKL CKMT2 CRIM1 C15orf42 CARM1 CCNDBP1 CDK16 CERS1 CKS1B CRISP2 C17orf28 CASC2 CCNE1 CDK17 CERS2 CKS2 CRKL C17orf37 CASC3 CCNE2 CDK18 CERS3 CLCA2 CRLF2 C17orf75 CASC5 CCNG1 CDK19 CERS4 CLDN3 CRMP1 C19orf35 CASK CCS CDK2 CERS5 CLDN4 CRYAB C19orf46 CASP2 CCT2 CDK20 CES2 CLK1 CSAG2 C20orf94 CASP3 CD2 CDK2AP1 CFLAR CLK2 CSF1R C21orf7 CASP8 CD274 CDK3 CHAF1A CLK3 CSF2 C2orf18 CASP9 CD70 CDK4 CHAF1B CLK4 CSK C2orf40 CASR CD9 CDK5 CHD1 CLN3 CSMD1 C6orf125 CAV1 CDC14A CDK5R1 CHD1L CLP1 CSNK1A1 C6orf204 CAV2 CDC14B CDK5R2 CHD2 CLU CSNK1D C7orf49 CBFA2T3 CDC20 CDK5RAP1 CHD3 CMPK1 CSNK1E Symbol CSNK1G1 CYLD DDX27 DHX33 DRAM1 EIF2AK1 EPHA7 CSNK1G2 CYTH2 DDX28 DHX34 DROSHA EIF2AK2 EPHA8 CSNK1G3 CYTH3 DDX39A DHX35 DSTYK EIF2AK3 EPHB1 CSNK2A1 DAB2 DDX39B DHX36 DTYMK EIF2AK4 EPHB2 CSNK2A2 DAB2IP DDX3X DHX38 DUS2L EIF2C1 EPHB3 CSNK2B DACT2 DDX3Y DHX40 DUSP1 EIF2C2 EPHB4 CSPG5 DAG1 DDX4 DHX57 DUSP12 EIF2S1 EPHB6 CST3 DAGLA DDX41 DHX8 DUSP16 EIF2S2 EPHX1 CST6 DAGLB DDX42 DHX9 DUSP2 EIF2S3 EPOR CTBP1 DAK DDX43 DICER1 DUSP21 EIF3B EPS15 CTBP2 DAPK1 DDX46 DIO1 DUSP26 EIF3G ERBB2 CTCFL DAPK2 DDX47 DIRAS3 DUSP28 EIF3H ERBB3 CTGF DAPK3 DDX49 DIXDC1 DUSP3 EIF4A1 ERBB4 CTNNA1 DAXX DDX5 DKK1 DUSP4 EIF4A2 ERC1 CTNNA2 DBC1 DDX50 DKK3 DUSP6 EIF4B ERCC1 CTNNB1 DBF4 DDX52 DLC1 DUSP7 EIF4E ERCC2 CTPS DCAKD DDX53 DLEC1 DUX4 EIF4G2 ERCC3 CTPS2 DCC DDX54 DLG1 DVL2 EIF4G3 ERCC4 CTRC DCK DDX55 DLG2 DYRK1A EIF5 ERCC5 CTRL DCLK1 DDX56 DLG3 DYRK1B ELAC2 ERG CTSA DCLK2 DDX58 DLG4 DYRK2 ELF4 ERN1 CTSB DCLK3 DDX6 DLX5 DYRK3 ELK3 ERN2 CTSC DCN DDX60 DMAP1 DYRK4 ELK4 ESCO1 CTSD DDA1 DEK DMD E2F1 ELL ESCO2 CTSE DDB2 DFFA DMGDH E2F3 ELOVL2 ESPL1 CTSF DDIT3 DGCR8 DMPK ECE1 EML4 ESR1 CTSG DDIT4 DGKA DNAJB4 ECHS1 ENDOG ESR2 CTSH DDR1 DGKB DNAJC2 ECT2 ENPP1 ESRRB CTSK DDR2 DGKD DNAJC6 EDN1 EP300 ETF1 CTSL1 DDX1 DGKE DNMBP EDNRA EPAS1 ETNK1 CTSL2 DDX10 DGKG DNMT1 EEF1A1 EPC1 ETNK2 CTSL3 DDX11 DGKH DNMT3B EEF2K EPC2 ETS1 CTSS DDX17 DGKI DOCK1 EFNA3 EPDR1 ETS2 CTSZ DDX18 DGKK DOCK10 EFNA4 EPGN ETV1 CTU1 DDX19A DGKQ DOCK2 EFNB3 EPHA1 ETV4 CUL3 DDX19B DGKZ DOCK3 EGF EPHA10 ETV5 CUL4B DDX20 DGUOK DOCK4 EGFR EPHA2 ETV6 CUL7 DDX21 DHODH DOCK8 EGR1 EPHA3 EWSR1 CUL9 DDX23 DHX15 DPM1 EHMT1 EPHA4 EXOSC10 CXorf61 DDX24 DHX16 DPP4 EHMT2 EPHA5 EXOSC4 CXXC4 DDX25 DHX29 DPYD EIF1B EPHA6 EXT1 Symbol EXT2 FGFR1OP FOXL2 GATA1 GPC6 HDAC2 HOPX EZH1 FGFR2 FOXM1 GATA2 GPER HDAC3 HOXA1 EZH2 FGFR3 FOXO1 GATA3 GPHN HDAC4 HOXA11 EZR FGFR4 FOXO3 GATA5 GPI HDAC5 HOXA5 FABP5 FGFRL1 FOXO4 GATAD2B GPX2 HDAC6 HOXA9 FADD FGR FOXP1 GBA GPX4 HDAC7 HOXB7 FANCA FH FOXP3 GBP2 GRB2 HDAC8 HOXB9 FANCC FHIT FOXQ1 GCK GRB7 HDAC9 HOXC11 FANCD2 FHL3 FPGS GDF15 GRIN2A HDGF HOXC6 FANCE FIGF FRK GFAP GRK1 HERPUD1 HOXD1 FANCF FILIP1L FSCN1 GIPC1 GRK4 HEXB HPGD FANCG FKBP4 FUK GJA1 GRK5 HFE HRAS FANCL FLCN FUNDC2 GJB1 GRK6 HGF HSF1 FANCM FLI1 FXN GJB2 GRK7 HIC1 HSN2 FAS FLJ40852 FXYD3 GK GRM1 HIC2 HSP90AA1 FASLG FLNA FXYD5 GK2 GRM3 HIF1A HSP90AB1 FASN FLNC FYN GK5 GRM8 HIF1AN HSPA1A FASTK FLOT1 FZR1 GKN2 GSG2 HIF3A HSPA1B FASTKD1 FLOT2 G2E3 GLDC GSK3A HIP1 HSPA2 FASTKD2 FLT1 G3BP1 GLI1 GSK3B HIPK1 HSPA4 FASTKD3 FLT3 G3BP2 GLI2 GSPT1 HIPK2 HSPA5 FASTKD5 FLT4 G6PD GLI3 GSTM1 HIPK3 HSPA8 FATE1 FN1 GAB1 GLI4 GSTM3 HIPK4 HSPA9 FBLN5 FN3K GAB2 GLIPR1 GSTP1 HIRA HSPB1 FBXO21 FN3KRP GABARAPL1 GLIPR1L1 GSTT1 HJURP HSPB2 FBXO31 FNBP1 GABARAPL2 GLIPR1L2 GTF2H1 HK1 HSPB8 FBXO5 FNDC3B GABPA GLIPR2 GTF2I HK2 HSPH1 FBXO8 FNTA GAD1 GLIS1 GUCY2C HK3 HTR2A FBXW10 FNTB GADD45A GLIS2 GUCY2D HKDC1 HTRA1 FBXW11 FOLH1 GADD45B GLIS3 GUCY2F HLF HUNK FBXW12 FOLR1 GADD45G GLS2 GUK1 HLTF HUWE1 FBXW7 FOS GAK GLYCTK H3F3A HMGA1 ICK FEN1 FOSB GAL GMNN HAS1 HMGA2 ID1 FER FOSL1 GALK1 GMPS HAS2 HMGN2P46 ID2 FES FOSL2 GALK2 GNAQ HAS3 HMOX1 ID4 FFAR2 FOXA1 GALNT12 GNAS HAT1 HNF1A IDH1 FGF19 FOXA2 GALR1 GNB2L1 HBEGF HNRNPA2B1 IDH2 FGF2 FOXC1 GAMT GNE HCK HNRNPAB IDO1 FGF20 FOXC2 GAS6 GNMT HDAC1 HNRNPK IDO2 FGF4 FOXD4 GAS7 GOLGA5 HDAC10 HNRPDL IFI16 FGFR1 FOXH1 GAST GPC3 HDAC11 HNRPLL IFNA1 Symbol IFNB1 IRS1 KIFC1 LIFR MAFA MAPK1 MCM5 IFNGR1 IRS2 KIT LIMA1 MAG MAPK10 MCM6 IGF1 ITGB1BP3 KLF10 LIMK1 MAGI1 MAPK11 MCM7 IGF1R ITK KLF4 LIMK2 MAGI2 MAPK12 MCTS1 IGF2BP1 ITPK1 KLF5 LMO1 MAGI3 MAPK13 MDK IGF2BP2 ITPKA KLF6 LMO2 MAK MAPK14 MDM2 IGF2BP3 ITPKB KLHDC10 LMO4 MAL MAPK15 MDM4 IGF2R ITPKC KLK10 LMTK2 MALT1 MAPK3 MDS1 IGFBP2 ITPR1 KLK11 LMTK3 MAML2 MAPK4 MED1 IGFBP3 JAG1 KLK13 LOC389906 MAP1B MAPK6 MED19 IGFBP5 JAK1 KLK15 LOC390877 MAP1LC3A MAPK7 MELK IGFBP6 JAK2 KLK2 LOC391533 MAP1LC3B MAPK8 MEN1 IHH JAK3 KLK3 LOC392226 MAP1LC3C MAPK9 MERTK IKBKB JUB KLK4 LOC442075 MAP2K1 MAPKAP1 MEST IKBKE JUN KLK5 LOX MAP2K2 MAPKAPK2 MET IKBKG JUNB KLK6 LOXL2 MAP2K3 MAPKAPK3 METTL6 IKZF1 KALRN KPNA2 LPAR1 MAP2K4 MAPKAPK5 METTL9 ILF3 KAT6A KRAS LPIN1 MAP2K5 MAPT MEX3B ILK KAT6B KSR1 LPP MAP2K6 MARCKS MEX3D ING1 KAT8 KSR2 LRP12 MAP2K7 MARK1 MFAP3L INPP5A KDM1A LAMP1 LRP1B MAP3K1 MARK2 MGMT INPPL1 KDM2A LAMP3 LRPPRC MAP3K10 MARK3 MIA INSR KDM2B LAMTOR2 LRRC10 MAP3K11 MARK4 MINK1 INSRR KDM4A LAMTOR3 LRRC4 MAP3K12 MAST1 MITF INTS6 KDM4C LAPTM4B LRRK1 MAP3K13 MAST2 MKNK1 IP6K1 KDM5A LASP1 LRRK2 MAP3K14 MAST3 MKNK2 IP6K2 KDM5B LATS1 LSAMP MAP3K15 MAST4 MKRN1 IP6K3 KDM5C LATS2 LSM1 MAP3K2 MASTL MLH1 IPMK KDM6A LBR LSM14A MAP3K3 MATK MLH3 IPPK KDM6B LCK LSM3 MAP3K4 MAU2 MLKL IQGAP1 KDR LCN2 LTBR MAP3K5 MBD2 MLL IQSEC1 KEAP1 LCP1 LTK MAP3K6 MBD3 MLL3 IRAK1 KHDRBS2 LEMD1 LUM MAP3K7 MBD4 MLL5 IRAK1BP1 KHK LEP LUZP4 MAP3K8 MBD6 MLST8 IRAK2 KIAA1804 LEPR LYN MAP3K9 MCAM MMD2 IRAK3 KIF11 LETMD1 LYPD6B MAP4 MCCC2 MME IRAK4 KIF14 LGALS3BP MACC1 MAP4K1 MCF2L MMP1 IRF3 KIF15 LGI1 MAD2L1 MAP4K2 MCL1 MMP10 IRF4 KIF1A LGR5 MAD2L2 MAP4K3 MCM2 MMP11 IRF5 KIF22 LHCGR MAEL MAP4K4 MCM3 MMP12 IRF6 KIF2C LHX3 MAF MAP4K5 MCM4 MMP13 Symbol MMP14 MPP7 NAP1L1 NHEJ1 NRBP2 PAK3 PDE2A MMP15 MRE11A NAP1L3 NHP2L1 NRK PAK4 PDE4D MMP16 MRPL41 NAT1 NIN NRP1 PAK6 PDE4DIP MMP17 MRPS2 NAT2 NINL NRP2 PAK7 PDGFB MMP19 MSH2 NBN NIPBL NSD1 PALB2 PDGFRA MMP2 MSH3 NCL NKRF NSF PALLD PDGFRB MMP20 MSH4 NCOA1 NKX2-1 NSMAF PANK1 PDGFRL MMP21 MSH5 NCOA3 NKX2-2 NSUN2 PANK2 PDIA4 MMP23A MSH6 NCOA4 NKX2-3 NTPCR PANK3 PDIK1L MMP23B MSI1 NCOA6 NKX3-1 NTRK1 PANK4 PDK1 MMP24 MSLN NDC80 NLK NTRK2 PAPSS1 PDK2 MMP26 MSR1 NDRG1 NMBR NTRK3 PAPSS2 PDK3 MMP27 MST1 NDRG2 NME1 NUAK1 PARD3 PDK4 MMP28 MST1R NDUFC2 NME2 NUAK2 PARD3B PDLIM2 MMP3 MTA1 NEDD8 NME3 NUDT6 PARD6G PDPK1 MMP7 MTA2 NEDD9 NME4 NUF2 PARK2 PDPN MMP8 MTAP NEFH NME5 NUMA1 PARK7 PDSS1 MMP9 MTCP1 NEGR1 NME6 NUP214 PARP1 PDSS2 MMPL1 MTMR6 NEK1 NME7 NUP62 PARP12 PDXK MN1 MTOR NEK10 NOD2 NUP88 PARP14 PDZD2 MOBKL1A MUSK NEK11 NONO NUP98 PASK PEA15 MOBKL1B MUTYH NEK2 NOP2 NUPR1 PATZ1 PEG3 MOBKL2A MVK NEK3 NOS1 NUSAP1 PAWR PELP1 MOBKL2B MYB NEK4 NOTCH1 OAS2 PAX2 PER1 MOBKL2C MYC
Load more

Recommended publications
  • Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
    ARTICLE https://doi.org/10.1038/s41467-020-18839-1 OPEN Aberrant methylation underlies insulin gene expression in human insulinoma Esra Karakose1,6, Huan Wang 2,6, William Inabnet1, Rajesh V. Thakker 3, Steven Libutti4, Gustavo Fernandez-Ranvier 1, Hyunsuk Suh1, Mark Stevenson 3, Yayoi Kinoshita1, Michael Donovan1, Yevgeniy Antipin1,2, Yan Li5, Xiaoxiao Liu 5, Fulai Jin 5, Peng Wang 1, Andrew Uzilov 1,2, ✉ Carmen Argmann 1, Eric E. Schadt 1,2, Andrew F. Stewart 1,7 , Donald K. Scott 1,7 & Luca Lambertini 1,6 1234567890():,; Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cell tumors that provide a molecular “recipe” or “roadmap” for pathways that control human beta cell regeneration. An earlier study revealed abnormal methylation in the imprinted p15.5-p15.4 region of chromosome 11, known to be abnormally methylated in another disorder of expanded beta cell mass and function: the focal variant of congenital hyperinsulinism. Here, we compare deep DNA methylome sequencing on 19 human insulinomas, and five sets of normal beta cells. We find a remarkably consistent, abnormal methylation pattern in insu- linomas. The findings suggest that abnormal insulin (INS) promoter methylation and altered transcription factor expression create alternative drivers of INS expression, replacing cano- nical PDX1-driven beta cell specification with a pathological, looping, distal enhancer-based form of transcriptional regulation. Finally, NFaT transcription factors, rather than the cano- nical PDX1 enhancer complex, are predicted to drive INS transactivation. 1 From the Diabetes Obesity and Metabolism Institute, The Department of Surgery, The Department of Pathology, The Department of Genetics and Genomics Sciences and The Institute for Genomics and Multiscale Biology, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
    [Show full text]
  • Frequency of ANKK1, DRD2, DRD3 Gene Polymorphisms in Refractory Schizophrenia Patients
    Frequency of ANKK1, DRD2, DRD3 gene polymorphisms in refractory schizophrenia patients F.D.D. Nunes1, J.A.F. Pinto1, P.H.B. Freitas2, L.L. Santos2 and R.M. Machado1 1 Pós-graduação em Enfermagem, Universidade Federal de São João Del Rei, Divinópolis, MG, Brasil 2 Pós-graduação em Ciências da Saúde, Universidade Federal de São João Del Rei, Divinópolis, MG, Brasil Corresponding author: F.D.D. Nunes E-mail: [email protected] Genet. Mol. Res. 18 (4): gmr18389 Received May 29, 2019 Accepted July 24, 2019 Published November 30, 2019 DOI http://dx.doi.org/10.4238/gmr18389 ABSTRACT. Schizophrenia is considered one of the most severe and complex mental disorders; it affects both the quality of life of the patient and his family. The dopamine hypothesis is the main concept concerning antipsychotic activity. Patients with treatment-refractory schizophrenia have a lower capacity for dopamine synthesis than those with a good response to first-generation antipsychotics. The polymorphisms rs1800497, rs1799732 and rs6280were chosen for evaluation because they are associated with decreased dopamine receptor expression and occur in genes encoding these receptors, namely, ANKK1, DRD2 and DRD3, respectively. This effect caused by these polymorphisms enhances refractoriness to treatment. We investigated the frequency of these polymorphisms and evaluated their association with refractory schizophrenia. This was a case- control molecular genetic study, with patients who were divided into three groups of 72 participants each: patients with refractory schizophrenia, with schizophrenia and controls with no diagnosis of any type of mental disorder. All participants of the research were from the extended Midwest region of Minas Gerais.
    [Show full text]
  • Nucleoporin 107, 62 and 153 Mediate Kcnq1ot1 Imprinted Domain Regulation in Extraembryonic Endoderm Stem Cells
    ARTICLE DOI: 10.1038/s41467-018-05208-2 OPEN Nucleoporin 107, 62 and 153 mediate Kcnq1ot1 imprinted domain regulation in extraembryonic endoderm stem cells Saqib S. Sachani 1,2,3,4, Lauren S. Landschoot1,2, Liyue Zhang1,2, Carlee R. White1,2, William A. MacDonald3,4, Michael C. Golding 5 & Mellissa R.W. Mann 3,4 1234567890():,; Genomic imprinting is a phenomenon that restricts transcription to predominantly one par- ental allele. How this transcriptional duality is regulated is poorly understood. Here we perform an RNA interference screen for epigenetic factors involved in paternal allelic silen- cing at the Kcnq1ot1 imprinted domain in mouse extraembryonic endoderm stem cells. Multiple factors are identified, including nucleoporin 107 (NUP107). To determine NUP107’s role and specificity in Kcnq1ot1 imprinted domain regulation, we deplete Nup107, as well as Nup62, Nup98/96 and Nup153. Nup107, Nup62 and Nup153, but not Nup98/96 depletion, reduce Kcnq1ot1 noncoding RNA volume, displace the Kcnq1ot1 domain from the nuclear periphery, reactivate a subset of normally silent paternal alleles in the domain, alter histone modifications with concomitant changes in KMT2A, EZH2 and EHMT2 occupancy, as well as reduce cohesin interactions at the Kcnq1ot1 imprinting control region. Our results establish an important role for specific nucleoporins in mediating Kcnq1ot1 imprinted domain regulation. 1 Departments of Obstetrics & Gynaecology, and Biochemistry, Western University, Schulich School of Medicine and Dentistry, London, ON N6A 5W9, Canada. 2 Children’s Health Research Institute, London, ON N6C 2V5, Canada. 3 Departments of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. 4 Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
    [Show full text]
  • Epha4/Tie2 Crosstalk Regulates Leptomeningeal Collateral Remodeling Following Ischemic Stroke
    EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke Benjamin Okyere, … , John B. Matson, Michelle H. Theus J Clin Invest. 2019. https://doi.org/10.1172/JCI131493. Research In-Press Preview Neuroscience Vascular biology Leptomeningeal anastomoses or pial collateral vessels play a critical role in cerebral blood flow (CBF) restoration following ischemic stroke. The magnitude of this adaptive response is postulated to be controlled by the endothelium, although the underlying molecular mechanisms remain under investigation. Here we demonstrated that endothelial genetic deletion, using EphA4f/f/Tie2-Cre and EphA4f/f/VeCahderin-CreERT2 mice and vessel painting strategies, implicated EphA4 receptor tyrosine kinase as a major suppressor of pial collateral remodeling, CBF and functional recovery following permanent middle cerebral artery occlusion. Pial collateral remodeling is limited by the cross talk between EphA4-Tie2 signaling in vascular endothelial cells, which is mediated through p-Akt regulation. Furthermore, peptide inhibition of EphA4 resulted in acceleration of the pial arteriogenic response. Our findings demonstrate EphA4 is a negative regulator of Tie2 receptor signaling which limits pial collateral arteriogenesis following cerebrovascular occlusion. Therapeutic targeting of EphA4 and/or Tie2 represents an attractive new strategy for improving collateral function, neural tissue health and functional recovery following ischemic stroke. Find the latest version: https://jci.me/131493/pdf 1 EphA4/Tie2
    [Show full text]
  • Peking University-Juntendo University Joint Symposium on Cancer Research and Treatment ADAM28 (A Disintegrin and Metalloproteinase 28) in Cancer Cell Proliferation and Progression
    Whatʼs New from Juntendo University, Tokyo Juntendo Medical Journal 2017. 63(5), 322-325 Peking University - Juntendo University Joint Symposium on Cancer Research and Treatment ADAM28 (a Disintegrin and Metalloproteinase 28) in Cancer Cell Proliferation and Progression YASUNORI OKADA＊ ＊Department of Pathophysiology for Locomotive and Neoplastic Diseases, Juntendo University Graduate School of Medicine, Tokyo, Japan A disintegrinandmetalloproteinase 28 (ADAM28) is overexpressedpredominantlyby carcinoma cells in more than 70% of the non-small cell lung carcinomas, showing positive correlations with carcinoma cell proliferation and metastasis. ADAM28 cleaves insulin-like growth factor binding protein-3 (IGFBP-3) in the IGF-I/IGFBP-3 complex, leading to stimulation of cell proliferation by intact IGF-I released from the complex. ADAM28 also degrades von Willebrand factor (VWF), which induces apoptosis in human carcinoma cell lines with negligible ADAM28 expression, andthe VWF digestionby ADAM28-expressing carcinoma cells facilitates them to escape from VWF-induced apoptosis, resulting in promotion of metastasis. We have developed human antibodies against ADAM28 andshown that one of them significantly inhibits tumor growth andmetastasis using lung adenocarcinoma cells. Our data suggest that ADAM28 may be a new molecular target for therapy of the patients with ADAM28-expressing non-small cell lung carcinoma. Key words: a disintegrin and metalloproteinase 28 (ADAM28), cell proliferation, invasion, metastasis, human antibody inhibitor Introduction human cancers 2). However, development of the synthetic inhibitors of MMPs andtheir application Cancer cell proliferation andprogression are for treatment of the cancer patients failed 3). modulated by proteolytic cleavage of tissue micro- On the other hand, members of the ADAM (a environmental factors such as extracellular matrix disintegrin and metalloproteinase) gene family, (ECM), growth factors andcytokines, receptors another family belonging to the metzincin gene andcell adhesionmolecules.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Human ADAM12 Quantikine ELISA
    Quantikine® ELISA Human ADAM12 Immunoassay Catalog Number DAD120 For the quantitative determination of A Disintegrin And Metalloproteinase domain- containing protein 12 (ADAM12) concentrations in cell culture supernates, serum, plasma, and urine. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION .....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ...................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE .................................................................................................................................2 TECHNICAL HINTS .................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ...................................................................................................3 OTHER SUPPLIES REQUIRED .............................................................................................................................................3 PRECAUTIONS .........................................................................................................................................................................4
    [Show full text]
  • Regulation of Transcription and Regulatory Networks for Muscle Growth * * * * A
    Regulation Of Transcription And Regulatory Networks For Muscle Growth * * * * A. Reverter , N.J. Hudson , Q. Gu and B.P. Dalrymple Introduction The advent of microarray gene expression technology has provided animal scientists with an unprecedented ability to profile the transcriptional changes during skeletal muscle growth. With respect to meat quality, most of the effort has concentrated on the understanding of fat and energy metabolism (reviewed by Hausman et al . (2009)). Graugnard et al . (2009) explored the network among 31 genes associated with aspects of adipogenesis and energy metabolism in bovine skeletal muscle and in response to two distinct diets. Also, Freyssenet (2007) reviewed the roles that energy-sensing molecules and mitochondria have in the regulation of gene expression in muscle. However, other mechanisms such as cell cycle, glycolysis, extra-cellular matrix, ribosomal proteins and the immune system play a significant role in development, and this role can work in a tissue-specific manner. Hudson et al . (2009a) reported various functional modules underpinning the transcriptional regulation of bovine skeletal muscle. The authors integrated a total of six gene co-expression networks, each developed using the PCIT algorithm (Reverter and Chan (2008)), and proposed a Module-to-Regulator heuristic by which those transcription factors (TF) with the highest average absolute correlation co-expression with the genes present in each module are deemed to be the relevant regulators. However, this Module-to-Regulator approach failed to capture some well-known regulators of muscle fibre type composition, and the use of more sophisticated methods such as the differential wiring approach of Hudson et al .
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • SUPPLEMENTARY TABLES and FIGURE LEGENDS Supplementary
    SUPPLEMENTARY TABLES AND FIGURE LEGENDS Supplementary Figure 1. Quantitation of MYC levels in vivo and in vitro. a) MYC levels in cell lines 6814, 6816, 5720, 966, and 6780 (corresponding to first half of Figure 1a in main text). MYC is normalized to tubulin. b) MYC quantitations (normalized to tubulin) for cell lines Daudi, Raji, Jujoye, KRA, KRB, GM, and 6780 corresponding to second half of Figure 1a. c) In vivo MYC quantitations, for mice treated with 0-0.5 ug/ml doxycycline in their drinking water. MYC is normalized to tubulin. d) Quantitation of changing MYC levels during in vitro titration, normalized to tubulin. e) Levels of Odc (normalized to tubulin) follow MYC levels in titration series. Supplementary Figure 2. Evaluation of doxycycline concentration in the plasma of mice treated with doxycycline in their drinking water. Luciferase expressing CHO cells (Tet- off) (Clonethech Inc) that is responsive to doxycycline by turning off luciferase expression was treated with different concentrations of doxycycline in culture. A standard curve (blue line) correlating luciferase activity (y-axis) with treatment of doxycycline (x- axis) was generated for the CHO cell in culture. Plasma from mice treated with different concentrations of doxycycline in their drinking water was separated and added to the media of the CHO cells. Luciferase activity was measured and plotted on the standard curve (see legend box). The actual concentration of doxycycline in the plasma was extrapolated for the luciferase activity measured. The doxycycline concentration 0.2 ng/ml measured in the plasma of mice correlates with 0.05 μg/ml doxycycline treatment in the drinking water of mice, the in vivo threshold for tumor regression.
    [Show full text]